
handle: 10550/94967
El empleo de fármacos promotores de la hemostasia se considera de gran importancia adyuvante en el manejo del sangrado. En el momento de la publicación de este capítulo, la aprotinina, un fármaco básicamente antifibrinolítico, se consideraba un paso importante en el control del sangrado. La controversia en relación con su empleo llevó, posteriormente, a su retirada del mercado tras una serie de publicaciones que ponían en duda su relación riesgo/beneficio
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
